Cel Sci Corp
CVM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000725363
In the last 90 days, Cel Sci Corp insiders filed 1 open-market purchase and 0 sales; 40 institutions reported holding it in 13F filings for Q2 2026, worth $2.08M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Cel Sci Corp changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 28 | 35 | +7 |
| Shares | 482.6K | 871.6K | +388.9K (+80.6%) |
| Value | $1.10M | $8.01M | +$6.91M (+625.2%) |
New holders (8)
Institutions that held Cel Sci Corp at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Commonwealth Equity Services, LLC | 175,209 | $1.61M | 0.00% |
| State Street Corp | 23,270 | $214.1K | 0.00% |
| Northern Trust Corp | 14,205 | $130.7K | 0.00% |
| US Bancorp | 8,695 | $80.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,112 | $19.4K | 0.00% |
| Group One Trading, L.P. | 111 | $1.02K | 0.00% |
| Alerus Financial NA | 38 | $350 | 0.00% |
| Advisory Services Network, LLC | 9 | $83 | 0.00% |
Sold out (1)
Institutions that held Cel Sci Corp at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Raymond James Financial Inc | 1,345 | $3.08K |